Facebook-f Linkedin-in

Colorectal Cancer

Key guidelines for oncology healthcare professionals are listed below

NICE Clinical Guidance Colorectal cancer prevention: colonscopic surveillance in adults with ulcerative colitis, Crohn’s disease or adenomas CG118
NICE Diagnostics Guidance Molecular testing strategies for Lynch syndrome in people with colorectal cancer DG27
NICE Diagnostics Guidance Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care DG56
NICE Diagnostics Guidance Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care DG30
NICE Interventional Procedures Guidance Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cancer IPG614
NICE Interventional Procedures Guidance Intraoperative electron beam radiotherapy for locally advanced and locally recurrent colorectal cancer IPG763
NICE Interventional Procedures Guidance Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancer IPG659
NICE Interventional Procedures Guidance Transanal total mesorectal excision for rectal cancer IPG713
NICE Guideline Colorectal cancer NG151
NICE Technology Appraisal Guidance Regorafenib for previously treated metastatic colorectal cancer TA866
NICE Technology Appraisal Guidance Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency TA716
NICE Technology Appraisal Guidance Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency TA709
NICE Technology Appraisal Guidance Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer TA668
NICE Technology Appraisal Guidance Cetuximab and panitumumab for previously untreated metastatic colorectal cancer TA439
NICE Technology Appraisal Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) TA240
NICE Technology Appraisal Guidance Trifluridine-tipiracil for previously treated metastatic colorectal cancer TA405
NICE Interventional Procedures Guidance Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer IPG532
NICE Interventional Procedures Guidance Preoperative high dose rate brachytherapy for rectal cancer IPG531
NICE Technology Appraisal Guidance Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy TA307
NICE Technology Appraisal Guidance Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer TA118
NICE Technology Appraisal Guidance Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer TA212
NICE Technology Appraisal Guidance Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes’ C) colon cancer TA100
NICE Technology Appraisal Guidance Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy TA242
NICE Technology Appraisal Guidance Guidance on the user of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61
NICE Technology Appraisal Guidance Laparoscopic surgery for colorectal cancer TA105
NICE Technology Appraisal Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal) TA334

Guidelines

Access key guidelines for oncology healthcare professionals

Click here

Resources

All the major resources from the world of oncology

Click here

Podcasts

We bring you informative podcasts with UK oncology experts

Click here

Events

Don't miss the latest oncology events in the UK

Click here

Are you a healthcare professional?

This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

Yes
No